Arendse LB, Murithi JM, Qahash T, Pasaje CFA, Godoy LC, Dey S, et al. The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages. Sci Transl Med. 2022;14(667):eabo7219. https://pubmed.ncbi.nlm.nih.gov/36260689/